Search Results for: hepatitis C virus

June 22, 2015July 2, 2015

China Rejects Gilead Patent Bid On $1,000-A-Day Hepatitis C Drug Sovaldi (Sofobuvir)

News

In response to news that the Chinese government patent office has denied a request by Gilead Sciences for a key patent on the hepatitis C drug sofosbuvir (trade name Sovaldi) ... Read more

June 18, 2015June 18, 2015

Hepatitis B Vaccine Less Effective In Patients With Rheumatoid Arthritis

News

Results recently presented during the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference demonstrated that patients suffering with rheumatoid arthritis (RA) are less likely to become protected by the hepatitis B vaccine when compared to the general population. ... Read more

June 4, 2015June 4, 2015

FDA Addresses Concerns Over Chronic Hepatitis C Therapy Approvals

Hepatitis C, News

The treatment options available to address chronic hepatitis C, a serious and life-threatening infection, have substantially improved over the years, and an ever-increasing number of novel HCV regimens with shorter treatment duration ... Read more

June 2, 2015June 2, 2015

Benitec Biopharma Signed Manufacturing Deal For Hepatitis C Treatment

Hepatitis C, News

Benitec Biopharma recently announced an agreement with Omnia Biologics, a Maryland-based biotechnology company, to manufacture materials for the TT-034 trial, the first-in-man clinical trial for hepatitis C treatment. The agreement was ... Read more

May 28, 2015May 28, 2015

AbbVie Presents Data On Hepatitis C Treatment In Japanese Patients

Hepatitis C, News

AbbVie recently presented new outcomes from the Phase 3 GIFT-I study of its all-oral, investigational, interferon (IFN)- and ribavirin (RBV)-free, 2-direct-acting antiviral treatment, ombitasvir/paritaprevir/ritonavir. The presentation took place at the Annual Meeting of the Japan ... Read more

May 26, 2015May 26, 2015

FDA Grants Breakthrough Therapy Designation for Genotype 1 Hepatitis C Therapy

Hepatitis C, News

The daclatasvir-sofosbuvir regimen for the treatment of genotype 1 hepatitis C patients was granted amended Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA). In the beginning of 2015, ... Read more

May 21, 2015May 28, 2015

Oxidized LDL Detection May Lead to the Development of New Hepatitis C Therapy

Hepatitis C, News

Findings from a new study recently published in the journal Cellular and Molecular Gastroenterology and Hepatology, the official journal American Gastroenterological Association, determined that a novel blood test is able ... Read more

April 30, 2015April 30, 2015

Study Reveals Hepatitis E Vaccine Can Protect Up to 4.5 Years

Hepatitis E, News

A new study conducted by a research group in China assessed a vaccine for Hepatitis E. The vaccine caused the production of antibodies and protected vaccine recipients from hepatitis E for up to ... Read more

April 29, 2015April 29, 2015

UK Report Makes Important Discovery Shows That Global Hepatitis B Epidemic Can Be Treated for $36 Per Person Per Year

Hepatitis B, News

Researchers from the University of Liverpool have recently released results from a report in which they analyzed the factors that influence the cost of manufacturing drugs for the Hepatitis B ... Read more

April 27, 2015April 27, 2015

Direct Antiviral Agents Significantly Decreases Hepatitis C Recurrence After Liver Transplantation

Hepatitis C, News

During the 50th International Liver Congress 2015 held in Vienna 22-26 of April in Austria, it was revealed that sofosbuvir (SOF)- and daclatasvir (DCV)-based regimens showed excellent results in patients with ... Read more